If your query includes the disease and Mesothelin and Claudin 18.2, you’re already searching smarter than before.

At the center of NCT07066995 is Mesothelin and Claudin 18.2 Dual-Target CAR-T

Therapy in Advanced Pancreatic Cancer, a study framed around advanced pancreatic cancer.

CAR-T means T cells are engineered to recognize specific markers, which is why the target names

in the title are more than just scientific decoration. This is the kind of wording that becomes useful

once broad searches stop feeling useful and the search shifts toward narrower trial categories. The

right move is to verify the details on the official study page and use that as a basis for a care-team

conversation.